User profiles for "author:Torbjorn Omland"
Torbjørn OmlandUniversity of Oslo Verified email at medisin.uio.no Cited by 35969 |
Prevention of cardiac dysfunction during adjuvant breast cancer therapy (PRADA): a 2× 2 factorial, randomized, placebo-controlled, double-blind clinical trial of …
G Gulati, SL Heck, AH Ree, P Hoffmann… - European heart …, 2016 - academic.oup.com
Aims Contemporary adjuvant treatment for early breast cancer is associated with improved
survival but at the cost of increased risk of cardiotoxicity and cardiac dysfunction. We tested …
survival but at the cost of increased risk of cardiotoxicity and cardiac dysfunction. We tested …
[PDF][PDF] B-type natriuretic peptides: a diagnostic breakthrough for clinicians
PA McCullough, T Omland, AS Maisel - Reviews in cardiovascular …, 2003 - Citeseer
B-type natriuretic peptide (BNP), a neurohormone synthesized in the cardiac ventricles, is
released as preproBNP and then enzymatically cleaved to the N-terminal-proBNP (NT …
released as preproBNP and then enzymatically cleaved to the N-terminal-proBNP (NT …
The Role of Cardioprotection in Cancer Therapy Cardiotoxicity: JACC: CardioOncology State-of-the-Art Review
Cardiotoxicity is a relatively frequent and potentially serious side effect of traditional and
targeted cancer therapies. Both general measures and specific pharmacologic …
targeted cancer therapies. Both general measures and specific pharmacologic …
[HTML][HTML] Rapid measurement of B-type natriuretic peptide in the emergency diagnosis of heart failure
AS Maisel, P Krishnaswamy, RM Nowak… - New England journal …, 2002 - Mass Medical Soc
Background B-type natriuretic peptide is released from the cardiac ventricles in response to
increased wall tension. Methods We conducted a prospective study of 1586 patients who …
increased wall tension. Methods We conducted a prospective study of 1586 patients who …
[HTML][HTML] The prognostic value of B-type natriuretic peptide in patients with acute coronary syndromes
JA De Lemos, DA Morrow, JH Bentley… - … England Journal of …, 2001 - Mass Medical Soc
Background Brain (B-type) natriuretic peptide is a neurohormone synthesized predominantly
in ventricular myocardium. Although the circulating level of this neurohormone has been …
in ventricular myocardium. Although the circulating level of this neurohormone has been …
[HTML][HTML] Plasma natriuretic peptide levels and the risk of cardiovascular events and death
Background The natriuretic peptides are counterregulatory hormones involved in volume
homeostasis and cardiovascular remodeling. The prognostic significance of plasma …
homeostasis and cardiovascular remodeling. The prognostic significance of plasma …
B-type natriuretic peptide and clinical judgment in emergency diagnosis of heart failure: analysis from Breathing Not Properly (BNP) Multinational Study
PA McCullough, RM Nowak, J McCord, JE Hollander… - Circulation, 2002 - Am Heart Assoc
Background—We sought to determine the degree to which B-type natriuretic peptide (BNP)
adds to clinical judgment in the diagnosis of congestive heart failure (CHF). Methods and …
adds to clinical judgment in the diagnosis of congestive heart failure (CHF). Methods and …
Association of troponin T detected with a highly sensitive assay and cardiac structure and mortality risk in the general population
Context Detectable levels of cardiac troponin T (cTnT) are strongly associated with structural
heart disease and increased risk of death and adverse cardiovascular events; however …
heart disease and increased risk of death and adverse cardiovascular events; however …
[HTML][HTML] A sensitive cardiac troponin T assay in stable coronary artery disease
Background In most patients with stable coronary artery disease, plasma cardiac troponin T
levels are below the limit of detection for the conventional assay. The distribution and …
levels are below the limit of detection for the conventional assay. The distribution and …
N-terminal pro-B–type natriuretic peptide and long-term mortality in acute coronary syndromes
Background—B-type natriuretic peptide (BNP) is a predictor of short-and medium-term
prognosis across the spectrum of acute coronary syndromes (ACS). The N-terminal fragment …
prognosis across the spectrum of acute coronary syndromes (ACS). The N-terminal fragment …